CAR T-Cell Therapy Guidance and Future Directions

Download this short summary slideset of key takeaway points from a live presentation on key considerations for managed care and specialty pharmacy professionals in integrating CAR T-cell therapy into the care of patients with hematologic malignancies.
Craig Freyer, PharmD
Zahra Mahmoudjafari, PharmD, BCOP, DPLA
Format: Microsoft PowerPoint (.ppt)
File Size: 1.08 MB
Released: August 11, 2021


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Related Content

On-demand webcast of live webinar: Multidisciplinary experts on the care of patients with lymphomas during COVID-19, from Clinical Care Options (CCO)

John Allan, MD Sandra E. Kurtin, PhD, ANP-C, AOCN Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: October 19, 2021 Expired: October 18, 2022

Download this expert-authored resource on current treatment algorithms for MDS from Clinical Care Options (CCO)

Jamile Shammo, MD, FASCP, FACP Released: October 18, 2021

Download this short slideset from Clinical Care Options (CCO) on recent advances in the treatment of systemic amyloidosis.

Beth Faiman, PhD, MSN, APRN-BC, AOCN Shaji K. Kumar, MD Released: October 18, 2021

Sagar Lonial, MD; Suzanne Lentzsch, MD, PhD; and Thomas G. Martin, MD discuss the use of BCMA-targeted agents in relapsed/refractory multiple myeloma in an on-demand webcast, from Clinical Care Options (CCO)

Sagar Lonial, MD
Program Director
Suzanne Lentzsch, MD, PhD Thomas G. Martin, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: October 15, 2021 Expired: October 14, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.